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PPP1 in 2009, Switzerland showed one of the highest 
HCE per capita in the world after the US [1]. Factors, 
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Abstract
Introduction: This study investigates the efficiency gains of integrated care models in Switzerland, since these models are regarded as 
cost containment options in national social health insurance. These plans generate much lower average health care expenditure than the 
basic insurance plan. The question is, however, to what extent these total savings are due to the effects of selection and efficiency.
Methods: The empirical analysis is based on data from 399,274 Swiss residents that constantly had compulsory health insurance with the 
Helsana Group, the largest health insurer in Switzerland, covering the years 2006–2009. In order to evaluate the efficiency of the different 
integrated care models, we apply an econometric approach with a mixed-effects model.
Results: Our estimations indicate that the efficiency effects of integrated care models on health care expenditure are significant. However, 
the different insurance plans vary, revealing the following efficiency gains per model: contracted capitated model 21.2%, contracted non-
capitated model 15.5% and telemedicine model 3.7%. The remaining 8.5%, 5.6% and 22.5%, respectively, of the variation in total health 
care expenditure can be attributed to the effects of selection.
Conclusions: Integrated care models have the potential to improve care for patients with chronic diseases and concurrently have a posi-
tive impact on health care expenditure. We suggest policy-makers improve the incentives for patients with chronic diseases within the 
existing regulations providing further potential for cost-efficiency of medical care.
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such as technological change and population expecta-
tions are pushing up health spending and will continue 
to drive costs even higher in the future [2]. The devel-
opment of health care expenditure in Switzerland is 
estimated for 2009 to amount to 61 billion Swiss francs 
and in 2010 to exceed 62.5 billion Swiss francs [3]. 
This represents approximately 11.5% of gross domes-
tic product (GDP) vs. 2 billion francs in 1960, with a 
share of around 5% of GDP. This growth corresponds 
to  an  annual  increase  of  roughly  7%  in  the  last  50 
years [1].
However,  compared  with  other  countries,  the  health 
care system in Switzerland is not only expensive, but 
also provides good to very good quality outcomes [4–6]. 
Higher health spending is reflected in the improvement 
of objective health indicators, such as life expectancy at 
birth. In Switzerland in 2008, this outcome indicator was 
82.2 years, which is behind Japan and is considered to 
be the second best value of the 30 OECD countries 
[1]. Given the high health care expenditure of the Swiss 
system, together with the fact that other countries have 
a similarly good system with significantly lower costs, 
the efficiency of the Swiss system and thus also neces-
sary reforms can be put into question [5].
The  aforementioned  OECD  analysis  of  the  Swiss 
health  system  brought  to  the  surface  the  fault  that 
medical provision is basically too fragmented. There is 
a lack of co-ordination. Overuse and misuse are often 
the result. Here Integrated Care2 (IC) may remedy the 
situation by linking providers to integrated networks. By 
vertically integrating health insurance and health care 
provision, IC may improve the allocation of resources in 
health care while limiting HCE. But what is integration 
and can one define integrated care? A good general 
definition of integrated care has been established by 
Kodner and Spreeuwenberg: “Integration is a coherent 
set of methods and models on the funding, administra-
tive, organisational, service delivery and clinical levels 
designed to create connectivity, alignment and collabo-
ration within and between the cure and care sectors. 
The goal of these methods and models is to enhance 
quality of care and quality of life, consumer satisfaction 
and system efficiency for patients with complex, long-
term problems cutting across multiple services, pro-
viders and settings. The result of such multi-pronged 
efforts to promote integration for the benefit of these 
special patient groups is called ‘integrated care.’”[7]. In 
Switzerland various methods and models in the area of 
IC can be found [8]. On the one hand integrated care 
models (ICM) and on the other hand various different 
methods and instruments, such as disease manage-
ment  [9],  case  management,  gatekeeping,  demand 
management,  chronic  care  management  or  guide-
lines. Very often these integration methods and instru-
ments are embedded and utilised in ICM. Our study 
focuses solely on the effects of integrated care models 
in Switzerland.
Social  health  insurance  (SHI)  is  compulsory  for  the 
population in Switzerland. Basic insurance allows the 
insured person the freedom of choice of doctors in the 
outpatient sector and unlimited access to general prac-
titioners and specialist physicians. Alternative forms of 
insurance exist with the option of restrained choice of 
medical providers granting policyholders discounts on 
the basic premium if they agree to sign up to integrated 
care models and only consult certain providers. The 
selected doctor or medical call centre incorporated in 
such an ICM acts as a family doctor, primary physi-
cian or gatekeeper. He covers all primary care and co- 
ordinates, if necessary, any further referrals to special-
ists or hospitals. Treatment and consultations without 
prior referral by the primary physician or telemedicine 
service are usually not covered by the health plan.
Switzerland  has  vast  and  lengthy  experience  within 
Europe in the development of integrated care models 
[10] and carries a wide range of insurance plans. In 
2009 nearly 37% of the Swiss population enrolled in 
these models, compared with a rate of 6.8% in 1998 
[11]. Figure 1 presents the development from 1998 to 
2009. This percentage would probably be even higher 
if the health insurance plans were to offer ICM in all 
cantons, regions and cities.
The  main  forms  of  integrated  care  models  in   
Switzerland can be characterised as follows:
Contract models with capitation
In  these  models  a  group  of  providers  incorporate  a 
network, which then makes a co-operation agreement 
with a health insurer. These networks can consist of 
a group of independent individual (general) practition-
ers  or  a  Health  Maintenance  Organisation  (HMO). 
Within the context of this contract, the network takes 
over collective responsibility for a financial budget. The 
remuneration by capitation gives the provider-network 
a calculated flat per capita allowance, for which it pro-
vides health care for the signed-up insured persons for 
a certain period. For this reason these models are also 
called per capita funding models. However, the finan-
cial budget is in practice merely a virtual cost target 
(virtual budget) and not a payment per se (disbursed 
budget). Providers do not receive a fixed periodic pay-
ment for each patient and are paid by the nationwide 
fee-for-service scheme. If the virtual budget is under-
shot at the end of the year, the difference is divided 
between the provider network and the health insurance 
2The concept of integrated care is in Switzerland a synonym for the well-
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aim of this offer is optimal supply of medical services 
for the patients signed up. This is done by medical pro-
fessionals answering patient questions with computer 
assistance and referring the patients in need of a doctor 
or a hospital. As in all ICM, the insured are obliged to 
consult their chosen gatekeeper, in this case the medi-
cal call centre, before turning to other medical provid-
ers. Approximately 21.4% of the insured have enrolled 
in this category of contract models without capitation, 
whereas 6.5% are in family doctor (B1) models and 
14.9% in medical call centre models (B2)4 [13].
Non-contracted models
Unlike both the above-mentioned models, the providers 
in the so-called list model are not contractually incorpo-
rated into a health insurance plan. These models are 
only insurance products, where the health insurer unilat-
erally defines lists of selectable medical service provid-
ers as gatekeepers. Often these list models are offered 
in regions without existing cooperation agreements with 
networks. Health plans utilise this form of ICM because 
of the possibility of applying premium rebates, which are 
naturally  very  popular  with  customers. Approximately 
11.6% of the insured have opted for this health plan 
form5. Insured persons enrolled in these non-contract 
models are excluded from our analysis in the present 
study. This is owing to the obviously extremely low co-
ordination and integration impact in the described non-
contracted models on health care provision.
plan  according  to  the  previously  contractual  agreed 
distribution. Therefore, the provider network will bene  fit 
from this participation. On the other hand, if the virtual 
budget is exceeded, the negative difference is shared 
accordingly. The provider network is required to pay 
its part of the difference to the insurer. Thus, Swiss 
integrated care models under capitation payment differ 
from health plans found abroad [12].
Nevertheless,  the  importance  of  the  capitation  lies 
probably not only in the financial incentive, but in the 
redistribution  of  responsibilities.  This  funding  model 
merges  medical  and  economic  responsibility.  Since 
economic responsibility includes the entire benefit of 
medical services3, the network also assumes responsi-
bility for the whole treatment process, particularly inter-
face  management  between  different  institutions  and 
specialities. This potentially leads away from volume 
based-medicine  to  more  patient  focused-care,  tak-
ing economic aspects into account. Of the nationwide 
37% of policyholders who have selected an IC model, 
approximately 4% are in a capitated ICM (year 2009) 
[13].
Contract models without capitation
The  attributes  of  these  models  are  identical  to  the 
above, except that the provider networks are not paid 
capitation.  In  addition  to  the  aforementioned  HMOs 
and the family doctor models, this category covers a 
new model variation: medical call centre or telemedi-
cine models. In Switzerland there are several call cen-
tres that focus on the provision of medical advice. The 
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Figure 1.  Proportion of population in an integrated care model per annum.
3The medical benefits covered by compulsory health insurance are defined 
by the federal government and are independent of the chosen health plan 
option.
4There are no current official figures on the insured for a further model dis-
tinction. For this reason, in order to achieve an approximation an internal ratio 
of a major health insurance/sickness fund was used from the year 2009.
5Residual value according to the previously calculated proportions (37% 
– 4% – 21.4%=11.6%; total ICM—capitated ICM—non-capitated ICM=non-
contracted model).
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The  raw  data  show  that  the  health  expenditure  of 
those subject to an ICM is 1675 Swiss francs is less 
than half that of those who remained with their original 
plan (4022 Swiss francs) [11]. However, the question 
arises, as to what extent these spending differences 
are due to the efficiency of integrated care models and 
whether they are moreover based on potential selec-
tion effects. Van de Ven et al. [14] already indicated 
the evidence of increasing risk selection tendencies in 
Switzerland in the area of integrated care, as in health 
insurers applying ICM-options, in order to attract good 
risks.  They,  therefore,  emphasised  the  importance 
of a good risk adjustment scheme in a competitive 
insurance market. This paper looks at the impact of 
integrated  care  models  on  health  care  expenditure 
in  Switzerland,  while  simultaneously  accounting  for 
selection effects and, therefore, makes a contribution 
to the discussion on possible expenditure containment 
measures.
The paper is structured as follows. Background section 
starts with a short review of the literature. Data and 
method section contains the data and descriptive sta-
tistics, as well as the method to estimate the efficiency 
effect of integrated care models on HCE. Results are 
shown and discussed in Empirical results section, while 
the last section ends with our conclusions.
Background
The objective of this paper is to investigate the effi-
ciency gains of integrated care models in Switzerland. 
A comprehensive review of the field of empirical liter-
ature most closely related to the question of interest 
is provided for international research studies in Glied 
[12] and specifically for Switzerland in Berchtold and 
Hess  [8,  15].  Generally,  existing  studies  found  that 
HMO-types  of  integrated  care  models  lower  health 
care expenditure. However, as Glied [12] points out, 
the  problem  of  selection  into  integrated  care  model 
health plans is of a great importance when focusing on 
the impact on HCE. Therefore research studies have 
to account for selection effects in order not to overes-
timate the effect of gatekeeping and other integrated 
care instruments through other unobserved variables.
To our knowledge, only four studies have previously 
analysed this field in Switzerland using individual data. 
Lehmann and Zweifel [16] estimated the efficiencies 
of a HMO, family doctor model and a list model using 
panel data from a Swiss health insurer. They found 
62% for the HMOs, 34% for the family doctor model 
and 39% for the list model, lower health care expen-
diture than for traditional plans. These cost savings 
are based, however, on evidence found for risk selec-
tion effects, which accounted for one-third of the cost 
advantage in the case of HMOs and less than half 
for the list model. The remaining substantial efficiency 
gain was assigned to innovation effects. Schwenk-
glenks et al. [17] assessed the economic efficiency of 
a family doctor plan compared with a fee-for-service 
plan in the region of Aarau, Switzerland. The study 
population  was  based  on  a  random  selection  from 
insurance  enrolment  files  and  finally  counted  466 
persons. The estimated results after the multivariate 
adjustment revealed cost savings of 15–19% due to 
the family doctor model. Beck [18] intensely studied 
the effect of managed care on the level of HCE by 
applying a matching technique, in order to estimate 
the efficiency gains on policyholders of a major Swiss 
health insurer. The study covered the years of 2006 
and 2007 and all 18 insurance models with a capita-
tion agreement, and corrected the morbidity discrep-
ancies  between  the  insurance  collectives.  Despite 
the variation of the results among different models, 
the investigated managed care plans were found to 
reduce health care expenditure on average by 8.7%. 
The best result was achieved by one of the models at 
18.5%, the worst model leading to a (statistically insig-
nificant) negative effect of –3%. Finally, Grandchamp 
and Gardiol [19] used a two-step model approach to 
estimate  empirically  the  efficiency  of  a  Swiss  tele-
medicine  service  using  claims’  data  from  a  Swiss 
health insurer covering 160,000 insured adults. They 
compared the health expenditure of insured persons 
in a telemedicine service model with those assigned 
to the conventional insurance plan. About 90% of the 
difference in health expenditure can be explained by 
selection and incentive effects. The remaining 10% 
of savings due to the efficiency of the telemedicine 
service amount to about 150 Swiss francs per year 
per insured.
The innovation to the preceding studies is that we ana-
lyse empirically the impact of ICM over a longer period 
of time as well as performing this for all contract-based 
models, meaning not only on capitated integrated care 
or telemedicine service models but also on non-capi-
tated ICM. Furthermore, we take up the request for a 
simpler method from Beck [18] and present an alterna-
tive methodical approach.
Data and method
Our  analysis  is  based  on  data  of  the  health  care 
insurance group, Helsana, the largest health insurer 
in Switzerland, including 1.37 million individuals with 
compulsory health insurance. As insurance switchers 
would introduce a possible bias in the efficiency esti-
mation, the utilised data sample comprises 399,274 
Swiss residents that constantly had compulsory health 
insurance  within  the  same  insurance  plan,  covering International Journal of Integrated Care – Volume 12, 13 January  – URN:NBN:NL:UI:10-1-101702 / ijic2012-2 – http://www.ijic.org/
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the years 2006–2009, i.e. a total of 1,597,096 obser-
vations. For each individual, we observe the annual 
amount of health care expenditure for the period in 
question. Furthermore, since our main objective is to 
investigate the efficiency impact of ICM over time, we 
incorporated only individuals with health care expendi-
ture during this period. Hence, individuals enrolled in 
a telemedicine call centre model who only addressed 
the call centre without any further health consultations 
were also not included in this investigation. This aspect 
is a potential source of bias and may lead to an under-
estimation of the efficiency effect in the telemedicine 
model.
It is reasonable to assume that this sample is highly 
reliable, since the administrative claims data collected 
by the insurer cover nearly all health care invoices. 
The Helsana Group offers the basic compulsory insur-
ance health plan as well as all aforementioned types 
of integrated care models. Therefore, the models in 
this study were divided into four groups: basic com-
pulsory insurance plan and contracted ICM, which has 
three categories: A) capitation model, B1) family doc-
tor model, and B2) telemedicine model. The ICM-share 
of the total insured has increased constantly over the 
period  in  question  from  13.7%  in  2006  to  30.6%  in 
2009. However, the variation between the various inte-
grated care models is vast. The most popular model is 
the B2) telemedicine model with a share of 18.9% of 
total insured in 2009, mainly owing to the fact that, in 
contrast to the other models, this model can be offered 
in all Swiss regions.
In  order  to  evaluate  the  efficiency  of  the  different 
integrated  care  models,  we  apply  an  econometric 
approach.  We  specify  the  following  empirical  model 
for the dependant variable cost ratio of total costs per 
individual i in year t, simultaneously summarising the 
independent variables:
f CRit =  


 


it it
it it it it it
DED CHRO
ACC CRPY PLAN NURS HOSP
,
, , , , ,
 
(1)
where:
CR    Cost ratio total costs: the total health expen-
diture of the individual in Swiss francs divided 
by  the  average  cantonal  health  expendi-
ture according to the Swiss risk equalisation 
scheme6. The distribution of the cost ratio for 
each insurance model is shown in Figure 2.   
The  corresponding  highlighted  colours  in   
Figure 2 are defined as follows: black, basic   
compulsory  insurance;  red,  A)  capitation  models;   
green,  B1)  family  doctor  model  and  blue,   
B2)  telemedicine  model.  The  distribution  of 
the ratio spread is askew (left plot), whereas 
the distribution of a logarithmic ratio (right plot) 
can well approximate a Gaussian distribution
HOSP    Hospital  stay:  dummy  variable  equal  to  1 
if  insured  showed  a  hospital  stay  of  more 
than 2 days in the preceding year and zero 
otherwise
NURS    Nursing home stay: dummy variable equal to 
1 if insured showed a nursing home stay of 
more than 2 days in the preceding year and 
zero otherwise
PLAN    Type of health plan: we defined three dummy 
variables according to the type of health plan 
chosen by member, whereas the compulsory 
basic  insurance  plan  is  the  according  refer-
ence value:
    Capitation model=CAP: dummy variable equal 
to  1  if  insured  is  a  member  of  a  capitation 
model and zero otherwise;
    Family  doctor  model=FDM:  dummy  variable 
equal to 1 if insured is a member of a family 
doctor model and zero otherwise;
    Telemedicine  model=TEL:  dummy  variable 
equal to 1 if insured is a member of a telemedi-
cine model and zero otherwise
CRPY    Cost  ratio  preceding  year:  the  total  health 
expenditure of the individual in Swiss francs, 
divided by the average cantonal health expen-
diture according to the Swiss risk equalisation 
scheme of the preceding year. These ratios are 
not used directly, but categorised into 24 differ-
ent groups of cost ratios. The first 20 groups 
are formed with approximately the same num-
ber of insured persons per group (4.8% per 
group). The group with the highest cost ratios 
is  then  further  divided  into  4  last  groups  in 
order to be able to handle the very high cost 
ratios more accurately. The cost ratios are ulti-
mately divided into 24 groups, leading to 23 
corresponding Dummy variables, whereas the 
first cost ratio group is the according reference 
value.
    In applying this variable to the included inte-
grated care models, we have to account for 
the assumption that the costs of the insured 
persons  enrolled  in  these  models  are  lower 
than the basic insurance scheme. Therefore, 
the corresponding costs of the preceding year 
need to be increased by the efficiency effect 
achieved to the level of the basic insurance 
scheme. Without applying this correction, the 
efficiency effect of integrated care models will 
6The average costs utilised in the Swiss risk equalisation scheme are pub-
lished annually and can be consulted on http://www.kvg.org/.This article is published in a peer reviewed section of the International Journal of Integrated Care  6
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ln(CRit)=β0+β1 HOSPit+
β2 NURSit +
β3_01 (PLAN=CAP)it +β3_02 (PLAN=FDM)it +β3_03 
(PLAN=TEL)it +
β4_02 (CRPY=Class=2)it+…+
β4_24 (CRPY=Class=24)it+
β5 ACCit+
β6_01 (CHRO=CHRO1)it+…+
β6_04 (CHRO=CHRO4)it+
β7 DEDit+αi+ εit  (2)
To choose the econometric approach, we consider the 
fact that the independent variables regarding the type 
of health plan (CAP, FDM and TEL) are of central sub-
stantive interest in the present study. The data of the 
year 2009 were used to develop the linear regression 
model with the variables shown. By reason of the fact 
that multiple records of data per person are present 
in this analysis, a linear regression is not feasible. To 
account for the different levels of cost ratios for the dif-
ferent individuals, the linear regression model, using 
fixed-effects,  is  augmented  with  a  random-effect  ai. 
The resulting mixed-effects model was calculated with 
the nlme package of R [www.r-project.org], proposed 
by Pinheiro and Bates [20]. The residual unexplained 
error term in linear regression corresponding to eit, is 
in this mixed-effects model divided into the random- 
effect ai (between group/person error) and the remain-
ing residual error term eit (within group/person error).
The  predictor  variables  presented  are  the  success-
ful subset of an earlier and larger set of predictors esti-
mated.  The  regression  model  building  and  covariate 
selection was performed step by step. Further candidates 
assessed were premium region, pharmacy cost groups 
and  various  interactions  between  covariates.  In  terms 
result to be too high. We describe the repeated 
process used further below.
ACC    Accident coverage: dummy variable equal to 1 
if insured possessed additional accident insur-
ance cover and zero otherwise
CHRO    Patients with a serious chronic disease such as 
diabetes, cardiac disorders or rheumatism have 
a pattern of high recurring costs over time. We 
assume that patients with a chronic illness can 
be identified by capturing the number of quarters 
within a year, in which claims were billed over 
the threshold of 500 Swiss francs. An insured 
person falls into our definition of chronic disease 
if the number of quarters is > 0. We therefore 
defined four dummy variables according to the 
number of quarters over the mentioned thresh-
old, whereas no quarters is the corresponding 
reference value:
    1 quarter=CHRO1: dummy variable equal to 
1 if insured has 1 quarter within a year over 
threshold and zero otherwise;
    2 quarters=CHRO2: dummy variable equal to 
1 if insured has 2 quarters within a year over 
threshold and zero otherwise;
    3 quarters=CHRO3: dummy variable equal to 
1 if insured has 3 quarters within a year over 
threshold and zero otherwise;
    4 quarters=CHRO4: dummy variable equal to 
1 if insured has 4 quarters within a year over 
threshold and zero otherwise
DED    Deductible class: dummy variable equal to 1 if 
insured chose a deductible higher than Swiss 
francs 500 and zero otherwise
The estimation of equation 1 requires the specification 
of a functional form. By applying this form, the model 
can be written as:
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Empirical results
The aim of this paper is to address the potential of 
efficiency effects in integrated care models in compari-
son with the basic compulsory insurance scheme in 
Switzerland. The handling of selection effects within 
the models is controlled in our econometric approach. 
Estimation results from mixed-effects model of equa-
tion 2 are presented in Table 2. The estimated sam-
pling  correlations  among  the  fixed-effect  coefficient 
estimates were analysed. The corresponding correla-
tions revealed very low levels among the coefficients 
to the central integrated care model variables (CAP, 
FDM and TEL) and, therefore, no further bias in this 
area can be stipulated.
Our results for the efficiency effects indicate that con-
tracted types of integrated care models in Switzerland 
are significantly associated with lower health expendi-
ture. However, the different insurance plans vary, reveal-
ing the following efficiency gains per model: contracted 
capitated model 21.2%, contracted non-capitated model 
15.5% and telemedicine model 3.7%. In terms of selec-
tion effects in the different models, the residual of the 
overall  average  cost  savings  mentioned  in  Data  and 
method section less the efficiency gains can be calcu-
lated. Table 3 illustrates the different effects per model.
These findings are consistent with previous studies, 
which  have  shown  that  health  care  costs  are  lower 
in integrated than in non-integrated systems [16–19, 
24]. However, apart from the telemedicine model, the 
impact of the stated efficiency effects in our investiga-
tion differentiates from prior studies. The total efficiency 
cost advantage is nearly exactly quantified between 
the values by Lehmann and Zweifel [16] and Beck [18] 
for the corresponding capitated models. The econo-
metric analysis performed by Lehmann provided high 
efficiency gain levels of –40% for the capitated models. 
Yet, the analysed insurance plan differs from the one 
in our study since it was based on HMOs that were 
operated and funded by a health insurer. This situation 
might lead to a more restrictive care treatment within 
the insurance-held own HMO and therefore to higher 
cost  savings.  Beck  described  the  efficiency  effects 
only of capitated models over 2 years and presented 
cost advantages of 8.7% and selection effects of about 
52%. In contrast to the findings of Beck, our selection 
effects play a less dominant role. Our estimations show 
selection effects of 8.5% on average in comparison to 
non-ICM-insured. The study design differs, however, 
to the present analysis and may be be put forward to 
explain the difference. In his study, efficiency gains are 
calculated for 18 individual physician networks sepa-
rately instead of for the insurance plan type as a whole. 
The corresponding results between the networks vary 
of the CHRO variable utilised, we also examined differ-
ent thresholds. Apart from the 500 Swiss francs, a 2500 
Swiss francs threshold was applied, plus various possible 
grouping options. Our final model was established from 
different combinations of predictor variables due to their 
significance and by applying likelihood ratio statistics.
According to prior research [21], the most essential and 
significant explanatory variable for health care expen-
diture estimations are the costs of the preceding year 
(CRPY). We applied this finding in our analysis at hand. 
As we already mentioned in the variable description of 
CRPY, we have to increase the corresponding costs of 
the preceding year by the achieved efficiency effect to 
the level of the basic insurance scheme. Without apply-
ing  this  correction,  the  efficiency  effect  of  integrated 
care models will result to be too high. One advantage of 
this study is that we base our analysis on four consecu-
tive years and estimate a continuous efficiency effect 
over the whole period. This calculation of the efficiency 
effects requires a repeated procedure. First of all, we 
corrected  the  CRPY  for  individuals  included  in  inte-
grated care models with an anticipated entry value, dif-
fering according to the model type, and then estimated 
the efficiency effect. Next, the achieved efficiency effect 
estimations were inserted as correction values for the 
costs of the preceding year and afterwards a new esti-
mation  was  performed.  This  procedure  was  contin-
ued until the model estimations were equivalent to the 
applied corrections made to CRPY. We tested different 
entry values for the corrections. Finally, they all led to 
the identical estimations for the efficiency effect and 
therefore we assume possession of a robust result.
Descriptive  statistics  for  the  sample  are  presented 
in Table 1. As can be seen and as expected, the cost 
ratios of all integrated care models were lower than in 
the sample covering the basic compulsory insurance 
model. The total effect of cost savings per model in com-
parison to the basic insurance scheme is –29.7% for the 
contracted models with capitation, –21.1% for Family 
doctor models and –22.5% for telemedicine models.
In order to derive a further explanation of the efficiency 
effects in integrated care models, we shall also com-
pare the cost ratios of the four most frequent pharmacy 
cost groups (PCG) between the four different insur-
ance plans. According to Lamers and van Vliet [22], 
PCGs identify patients with a serious chronic illness by 
means of drug claims submitted for the corresponding 
medicines prescribed. Our Swiss definition of the util-
ised pharmacy cost groups is based on Beck [23] and 
distinguishes between 13 different groups7.
7Asthma/chronic obstructive pulmonary disease (COPD), epilepsy, rheuma-
tism, cardiac disorders, Crohn’s disease/ulcerative colitis, gastric disorders, 
diabetes types I and II, Parkinson’s disease, transplants, cancer, HIV/AIDS 
and kidney disorders.This article is published in a peer reviewed section of the International Journal of Integrated Care  8
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Table 1. Sample characteristics on variables
Basic compulsory 
insurance model with  
free choice of provider
A) Contracted models 
with capitation
B) Contracted models without 
capitation
B1) Family  
doctor model
B2) Telemedicine 
model
i 1,430,704 20,336 45,976 100,080
t 2006–2009 2006–2009 2006–2009 2006–2009
N 357,676 5084 11,494 25,020
Cost ratio total costs mean 1.535 1.079 1.211 1.190
Std. dev. 3.737 2.265 3.038 2.706
Age groups
  0–18 years 12.60% 6.88% 6.95% 10.77%
  19–25 years 4.52% 3.63% 4.14% 4.90%
  26–30 years 2.75% 2.67% 1.57% 2.72%
  31–35 years 3.45% 3.57% 1.57% 3.54%
  36–40 years 4.33% 4.89% 2.44% 4.61%
  41–45 years 5.54% 6.32% 4.29% 5.92%
  46–50 years 6.14% 7.14% 5.69% 6.75%
  51–55 years 6.96% 6.90% 6.93% 8.31%
  56–60 years 8.31% 7.34% 8.57% 10.20%
  61–65 years 9.20% 8.78% 9.97% 11.62%
  66–70 years 8.60% 8.90% 10.75% 9.45%
  71–75 years 8.75% 10.68% 11.96% 8.43%
  76–80 years 8.15% 10.58% 11.23% 6.39%
  81–85 years 6.20% 7.47% 8.50% 4.20%
  86–90 years 3.24% 3.25% 4.02% 1.69%
  91-years 1.26% 0.99% 1.42% 0.49%
Deductible class (>500 Swiss francs) 9.76% 17.89% 10.24% 28.60%
Hospital stay 13.01% 11.28% 13.00% 10.69%
Nursing home stay 3.05% 1.79% 3.48% 1.09%
Accident coverage 23.25% 29.22% 23.65% 31.50%
Chronic patient
  Nq500
  0 quarter 25.83% 29.62% 26.67% 31.32%
  1 quarter 19.60% 21.37% 20.68% 22.41%
  2 quarters 15.77% 16.73% 16.51% 16.11%
  3 quarters 14.86% 14.29% 15.05% 13.68%
  4 quarters 23.94% 17.98% 21.09% 16.49%
Female 60.43% 58.88% 59.81% 59.68%
Cost ratio preceding year classes
 1 4.63% 6.28% 4.44% 6.48%
 2 4.68% 5.51% 4.79% 5.82%
 3 4.69% 5.39% 4.92% 5.61%
 4 4.71% 5.31% 4.84% 5.41%
 5 4.71% 5.38% 5.04% 5.21%
 6 4.72% 4.98% 5.03% 5.14%
 7 4.73% 4.85% 5.07% 5.00%
 8 4.73% 4.79% 5.27% 4.98%
 9 4.75% 4.80% 4.84% 4.87%
  10 4.75% 4.50% 4.89% 4.87%
  11 4.76% 4.55% 4.91% 4.73%
  12 4.77% 4.54% 4.86% 4.70%
  13 4.79% 4.43% 4.56% 4.57%
  14 4.79% 4.59% 4.74% 4.40%
  15 4.80% 4.55% 4.69% 4.26%
  16 4.80% 4.39% 4.64% 4.42%
  17 4.82% 4.28% 4.47% 4.17%
  18 4.83% 3.97% 4.40% 4.15%
  19 4.83% 4.48% 4.59% 3.95%
  20 4.84% 4.26% 4.65% 3.81%
  21 1.21% 1.02% 1.25% 0.88%
  22 1.22% 1.04% 1.04% 0.89%
  23 1.22% 1.01% 1.03% 0.90%
  24 1.23% 1.06% 1.05% 0.76%International Journal of Integrated Care – Volume 12, 13 January  – URN:NBN:NL:UI:10-1-101702 / ijic2012-2 – http://www.ijic.org/
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Table 2. Econometric results
Variable Mixed-effects model 
Coefficient [95% CI]
Std. Err. Effect in per centa
Hospital stay (HOSP)   0.959 [0.955; 0.962]*** 0.002 160.8%
Nursing home stay (NURS)   0.241 [0.233; 0.250]*** 0.004   27.3%
Insurance plan (PLAN)
  Capitated model (CAP) –0.239 [–0.257; –0.221]*** 0.009   –21.2%
  Family doctor model (FDM) –0.169 [–0.182; –0.157]*** 0.006   –15.5%
  Telemedicine model (TEL) –0.038 [–0.046; –0.029]*** 0.004   –3.7%
Cost ratio preceding year (CRPY)
  Class 2 –0.108 [–0.114; –0.101]*** 0.003   –10.2%
  Class 3 –0.126 [–0.134; –0.120]*** 0.003   –11.9%
  Class 4 –0.122 [–0.129; –0.115]*** 0.003   –11.5%
  Class 5 –0.110 [–0.117; –0.103]*** 0.003   –10.4%
  Class 6 –0.101 [–0.108; –0.094]*** 0.003   –9.6%
  Class 7 –0.090 [–0.098; –0.083]*** 0.003   –8.7%
  Class 8 –0.082 [–0.089; –0.076]*** 0.003   –7.9%
  Class 9 –0.068 [–0.075; –0.061]*** 0.003   –6.5%
  Class 10 –0.058 [–0.065; –0.051]*** 0.004   –5.6%
  Class 11 –0.039 [–0.046; –0.033]*** 0.004   –3.9%
  Class 12 –0.033 [–0.040; –0.026]*** 0.004   –3.2%
  Class 13 –0.017 [–0.024; –0.010]*** 0.004   –1.7%
  Class 14 –0.004 [–0.011; 0.003] 0.004   –0.4%
  Class 15   0.018 [0.011; 0.025]*** 0.004   1.8%
  Class 16   0.043 [0.036; 0.050]*** 0.004   4.4%
  Class 17   0.064 [0.056; 0.070]*** 0.004   6.6%
  Class 18   0.094 [0.087; 0.101]*** 0.004   9.9%
  Class 19   0.131 [0.124; 0.138]*** 0.004   14.0%
  Class 20   0.208 [0.200; 0.214]*** 0.004   23.1%
  Class 21   0.300 [0.289; 0.310]*** 0.006   35.0%
  Class 22   0.382 [0.371; 0.393]*** 0.006   46.5%
  Class 23   0.513 [0.501; 0.524]*** 0.006   67.0%
  Class 24   0.786 [0.773; 0.798]*** 0.006 119.4%
Accident coverage (ACC)   0.219 [0.215; 0.223]*** 0.002   24.5%
Chronic patients (CHRO)
  1 Quarter (CHRO1)   1.121 [1.118; 1.125]*** 0.002 206.9%
  2 Quarters (CHRO2)   1.562 [1.558; 1.565]*** 0.002 376.8%
  3 Quarters (CHRO3)   1.861 [1.857; 1.865]*** 0.002 542.8%
  4 Quarters (CHRO4)   2.150 [2.156; 2.154]*** 0.002 758.4%
Deductible class (DED) –0.151 [–0.157; –0.145]*** 0.003   –14%
Constant –1.845 [–1.852; –1.839]*** 0.003   –84.2%
Random effects Std. Err.
  Between group error   0.6075
  Within group error   0.5651
*p<0.10, **p<0.05, ***p<0.01
a)The regression analysis determines the regression coefficient β of each independent variable. In order to obtain the impact in percent of the dummy variables, 
the following further transformation of the coefficients is applied exp(β) – 1
greatly from –3.7% to –18.5%8. Other types of inte-
grated  care  models  were  not  analysed  by  Beck.  In 
terms of the efficiency effect found for family doctor 
models (–15.5%) the expected result is perfectly in line 
with the effect of –15 to –19% identified by Schwenk-
glenks et al. [17] and more or less comparable with 
the study performed by Lehmann with efficiency gains 
of –10%. The quantified efficiency effect for this type 
of integrated care model seems to be rather consis-
tent over the years. His study covered the years from 
1997  to  2000. The  present  investigation  covers  the 
years from 2006 to 2009 and we presume that there 
has been some kind of development in the area of 
family doctor models within the last decade. Expected 
positive results were found with the effects generated 
by telemedicine models. The efficiency effect (3.7%) 
is consistent with prior findings by Grandchamp and 
Gardiol [19].
The central instrument of the current integrated care 
models in Switzerland is gatekeeping. The gatekeeper 
tries to coordinate the care of patients among multi-
ple providers in order to avoid wasteful duplication of 
8We refer only to the significant results and therefore ignore the physician 
networks with a statistically insignificant result.This article is published in a peer reviewed section of the International Journal of Integrated Care  10
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This study has several strengths. To our knowledge 
and contrary to other studies, it is the first empirical 
investigation to have applied a uniformed analysis for 
all types of contracted integrated care models found 
in Switzerland. This guarantees a uniform data set 
and presents an ideal comparison for the estimation 
of potential efficiency effects in these types of insur-
ance plans. In addition, our analysis is based on a 
period of four consecutive years, which allows us to 
capture the long-term efficiency effect and to reduce 
possible bias’ due to individual changes of insurance 
models or changes of social health insurer within the 
period.
We also want to point out a limitation of our study. 
From  previous  unpublished  research9,  we  estimate 
that 2–3% of all claims invoices are paid directly by the 
patient (e.g. due to high deductibles chosen) and not 
reimbursed by the health insurer. This may lead to a 
possible bias due to a mixture of the different effects in 
the estimation and missing claims data.
Conclusion
This empirical study reaffirms that integrated care mod-
els can contribute effectively and recurring as a cost 
containment measure in the Swiss health care system. 
Our  attempt  to  investigate  the  differences  in  health 
care expenditure due to efficiency effects rather than 
mere risk selection was based on a panel dataset from 
a major Swiss health insurer with 399,274 insured indi-
viduals, covering the years 2006–2009. By controlling 
the effects of risk selection the average gross reduction 
in costs achieved by capitated integrated care models, 
such as HMO, attain 21.2% in comparison with the 
basic insurance scheme. Family doctor models without 
capitation financing and the telemedicine models show 
lower cost savings of 15.5% and 3.7%, respectively. 
These results are robust and are consistent with pre-
vious research findings in Switzerland. However, we 
must stress that the aforementioned efficiency effects 
represent an average figure per model. For example, 
diagnostic testing, perilous poly-pharmacy and confu-
sion over conflicting care plans. A potential reason for 
the stated efficiency effects in integrated care mod-
els may be due to better co-ordination and integration 
of medical provision leading to a more effective and 
efficient delivery of care. Previous research reveals 
the importance of care co-ordination [8, 15, 25–27] 
and indicates the potential for continuous cost con-
tainment by applying integrated care models. It also 
concurrently indicates with these, the corresponding 
instruments in the health care system. A comparison 
of the cost ratios of the four most frequent pharmacy 
cost groups (PCG) between the four different insur-
ance plans can be put forward in order to explain the 
efficiency effects achieved in integrated care models. 
Table 4 presents the corresponding values per insur-
ance model. The results corroborate the assumption 
that integrated care models can exert a positive finan-
cial impact by a better co-ordination of medical care, 
especially in the area of chronic diseases. The cost 
ratio of common chronic diseases, such as asthma 
and  chronic  obstructive  pulmonary  disease  in  capi-
tated models are treated 31% more cost-efficient than 
the same chronic patient group in the basic compul-
sory insurance scheme.
However,  apart  from  the  aforementioned  effects 
on health expenditure, integrated forms of practice 
also provide higher quality of care. The findings of 
previous research display that physician group type 
influences health care quality considerably [28–31]. 
Therefore, in summary, as we look for more efficient 
health care delivery and better quality of care, it may 
be worthwhile to look at integrated care models as 
an example of an efficient and high quality model in 
Switzerland.
Turning to the remaining exogenous factors, the regres-
sion analyses also show that they are statistically sig-
nificant at the 99% confidence level. This indicates that 
these  variables  should  be  taken  into  account  when 
conducting future research in this area. The effect on 
the dependent variable cost ratio differs, however, to 
great extent. Variables with a very strong influence are 
chronic patients, hospital last year and cost ratio in the 
previous year. A surprisingly small impact is exerted by 
the variable deductible class.
9Achermann R. Abrechnungseffekte bei der Umstellung von tiers garant 
zu tiers payant. [Accounting effects in the transition from tiers garant to tiers 
payant.] Zurich: Helsana; 2006. [in German].
Table 3. Calculation of the different effects by insurance model
Effect A. Contracted models 
with capitation
B1. Contracted models   
without capitation
3B2. Telemedi-
cine  
models
Overall average cost savings –29.7% –21.1% –22.5%
  There from efficiency effects –21.2% –15.5%   –3.7%
  There from selection effects   –8.5%   –5.6% –18.8%International Journal of Integrated Care – Volume 12, 13 January  – URN:NBN:NL:UI:10-1-101702 / ijic2012-2 – http://www.ijic.org/
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